MyFinsight
Home
Blog
About
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-32,146
-12,922
-27,599
-29,931
Return on Equity
-9,861.18
-15,440.251
-13,254.849
-13,040.348
Net Profit Margin
-926.983
-
-
-
Debt to Asset Ratio
20.709
29.57
29.661
28.297
Cash Ratio
121.745
106.986
158.972
118.792
Quick Ratio
1,071.642
964.677
792.732
819.021
Current Ratio
1,071.642
964.677
792.732
819.021
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Show more